Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V3381 (Indantadol) in Chronic Cough
NCT01401673Phase 2Terminated
- Sponsor
- Vernalis
- Start
- Oct 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indantadol in chronic cough, sponsored by Vernalis. Started Oct 2009; status: terminated.
02
Drugs
indantadol
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT01401673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01401673.